Hepatic Arterial Infusion Pump Chemotherapy in Patients With Unresectable Intrahepatic Cholangiocarcinoma—PUMP-2 Trial
Stijn Franssen(Erasmus MC Cancer Institute), Bas Groot Koerkamp, Wills F. Filipe(Erasmus MC Cancer Institute), Heinz‐Josef Klümpen(University Medical Center Groningen), Florian E. Buisman(Erasmus MC), Marjolein Y.V. Homs(Erasmus MC Cancer Institute), Jeroen Hagendoorn(Utrecht University), Nadia Haj Mohammad(Utrecht University), Merve Rousian(Erasmus MC Cancer Institute), B. Ten Haaft(University of Amsterdam), Bianca Mostert(Erasmus MC), Michael Doukas(Erasmus MC), Rutger‐Jan Swijnenburg(Amsterdam University Medical Centers)
Cited by 5
Related Papers
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trial
|The Lancet. Gastroenterology & hepatology|2019|597
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma
|New England Journal of Medicine|2023|530